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Customized Corneal Cross-Linking—
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Purpose: To improve the safety, reproducibility, and depth of effect
of corneal cross-linking with the ultraviolet A (UV-A) exposure time
and ﬂuence customized according to the corneal thickness.
Methods: Twelve human corneas were used for the experimental
protocol. They were soaked using a transepithelial (EPI-ON) technique
using riboﬂavin with the permeation enhancer vitamin E–tocopheryl
polyethylene glycol succinate. The corneas were then placed on
microscope slides and irradiated at 3 mW/cm2 for 30 minutes. The
UV-A output parameters were measured to build a new equation
describing the time-dependent loss of endothelial protection induced
by riboﬂavin during cross-linking, as well as a pachymetry-dependent
and exposure time-dependent prescription for input UV-A ﬂuence.
The proposed equation was used to establish graphs prescribing the
maximum UV-A ﬂuence input versus exposure time that always
maintains corneal endothelium exposure below toxicity limits.
Results: Analysis modifying the Lambert–Beer law for riboﬂavin
oxidation leads to graphs of the maximum safe level of UV-A
radiation ﬂuence versus the time applied and thickness of the treated
cornea. These graphs prescribe UV-A ﬂuence levels below 1.8 mW/cm2
for corneas of thickness 540 mm down to 1.2 mW/cm2 for
corneas of thickness 350 mm. Irradiation times are typically
below 15 minutes.
Conclusions: The experimental and mathematical analyses establish
the basis for graphs that prescribe maximum safe ﬂuence and UV-A
exposure time for corneas of different thicknesses. Because this clinically
tested protocol speciﬁes a corneal surface clear of shielding riboﬂavin on
the corneal surface during UV-A irradiation, it allows for shorter UV-A
irradiation time and lower ﬂuence than in the Dresden protocol.
Key Words: corneal cross-linking, transepithelial cross-linking, low
ﬂuence cross-linking
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Corneal collagen cross-linking (CXL), originally describedby Spoerl et al,1 is now an important corneal strength-
ening procedure in treatment of keratoconus2,3 and post-
operative laser in situ keratomileusis corneal ectasia.4 Cross-
linking can signiﬁcantly increase biomechanical stiffness of
the cornea.2,3,5 In the standard Dresden cross-linking protocol
for keratoconus treatment, the cornea is deepithelialized and
then soaked in riboﬂavin for 30 minutes. The treated cornea is
then irradiated with ultraviolet A (UV-A; 370 nm) at a power
of 3 mW/cm2 for 30 minutes for a total input energy from the
UV-A source of 5.4 J/cm2 while continually replenishing the
corneal surface with riboﬂavin phosphate 0.1%.1,6 Cross-
linking with the Dresden protocol produces cross-linking to
a depth of 250 to 350 mm; thus, a minimum corneal thickness of
400 mm is recommended7 or application of hypotonic solution
to the cornea to create a corneal thickness of 400 mm.8
Two basic assumptions for determining proper UV-A
ﬂuence and total energy for cross-linking are ﬂawed assump-
tions. Reexamining these assumptions seems to lead to
a possibly safer, more widely usable, and more reproducible
cross-linking procedure.
One assumption, called the Bunsen–Roscoe law, has
been used to justify more rapid cross-linking than the 1-hour
Dresden protocol. The Bunsen–Roscoe law implies that the
same corneal strengthening effect could be achieved by
applying higher UV-A ﬂuence over a shorter time but with the
same total energy of 5.4 J/cm2 as in the Dresden protocol. But
endothelial toxicity and existing published data on effective-
ness limit the use of the Bunsen–Roscoe law. Endothelial
toxicity determines the safety limit of UV-A power. A study by
Wollensak et al9 demonstrated that UV-A rays elicit cytotoxic
activity at 0.65 J/cm2 (0.35 mW/cm2). Furthermore, higher-
ﬂuence shorter-duration cross-linking seems to produce only
a relatively shallow cross-linking effect. Kymionis et al10
demonstrated clinically that the 30-minute 3-mW/cm2 UV-A
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intensity Dresden protocol for CXL yielded a deeper corneal
effect than did a shorter more intense treatment of a 10-minute
9-mw/cm2 CXL protocol. Recent experimental work by Wernli
et al11 also disproved the Bunsen–Roscoe law for UV-A
ﬂuence much higher than in the Dresden protocol. In fact,
clinical results by Caruso et al12 indicated that effective cross-
linking could be accomplished using half the UV-A ﬂuence of
the Dresden protocol and also a shorter exposure time than
described in the Dresden protocol.
The second ﬂawed assumption is the Lambert–Beer law
used to describe an exponential decline in UV-A power
versus depth in the irradiated cornea during cross-linking.13 In
addition, experimental data provided the basis for the pro-
posed 400-mm lower limit of minimal pachymetry in the
original Dresden protocol for safe cross-linking. It is also the
reason for continually adding riboﬂavin during UV-A irradi-
ation.14 But the Lambert–Beer law grossly oversimpliﬁes the
actual UV-A absorption kinetics during cross-linking. When
a cornea is fully soaked in riboﬂavin phosphate for 30 mi-
nutes, most of the UV-A absorption and endothelial pro-
tection result from the unoxidized riboﬂavin within the
corneal tissue, not the corneal tissue itself. But endothelial
protection from riboﬂavin in epithelium-off (EPI-OFF) cross-
linking has been shown to be time-varying during treatment
as the riboﬂavin disappears from oxidation.15
The Dresden protocol is well tested, safe, and effective,
and its safety depends on adding more riboﬂavin during the
UV-A irradiation process. The surface riboﬂavin absorbs
much of the UV-A energy input, thus protecting the
endothelium. But adding more riboﬂavin onto the corneal
surface produces a time-varying thickness of riboﬂavin on the
corneal surface that blocks UV-A absorption in an erratic and
highly time-variable way by acting as a “sunscreen” for UV-
A transmission during treatment. The thickness of the
riboﬂavin ﬁlm varies constantly, thus inducing large varia-
tions in UV-A intensity and transmission to the corneal
stroma where corneal strengthening is needed.14
UV-A blockage can vary by the patient and by the
technique used by the person applying the riboﬂavin. This
variation could cause a differential stiffening effect at different
depths within the treated corneas and among the treated eyes.
This study explores the mathematics of cross-linking and
leads to a prescription of a customized cross-linking treatment
based on corneal pachymetry that includes corneas thinner than
400 mm. We previously investigated the pharmacological,
chemical, physical, and biological basis underlying CXL
treatments with laboratory experiments, and we demonstrated
the clinical effectiveness and safety of TE-CXL treatments with
a newly proposed permeation enhancer (vitamin E–tocopheryl
polyethylene glycol succinate) (VIT-E-TPGS) and lower-
ﬂuence shorter-duration UV-A exposure with respect to the
Dresden protocol as discussed in previous studies.12,15,16
MATERIALS AND METHODS
This research adhered to the tenets of the Declaration of
Helsinki. Approval from the Institutional Review Board/
Ethics Committee and Animal Care and Use Committee was
obtained (authorization no. 1269).
Cross-Linking Solution
The solution contained riboﬂavin 0.125%, D-alpha-
tocopheryl polyethylene glycol 1000 succinate (VE-TPGS)
(IROMED, Rome, Italy).
Corneal Samples
Twelve human corneas were used for the experimental
protocol. Human corneas, not suitable for transplantation
because of biological contamination of the carrier solution
(Optisol GS; Bausch & Lomb, Rochester, NY), were pro-
vided by the spin-off consortium Fast-linking S.r.l. and by the
Pellegrini Hospital Regional Eye Bank, Naples, Italy.
All samples showed intact epithelium, normal density
of endothelial cells, and absence of epithelial or stromal
opaciﬁcation. Before experimentation, each cornea was
excised circularly 2 mm from the limbus, and central
thickness (d) of the sample was measured with a 5-mm
resolution ultrasound pocket pachymeter (Quantel Medical,
Clermont, France).
Spectrophotometric Measurements
The UV-A source used in this study (CF–X Linker
Modulated; IROMED) contains light-emitting diodes with
a 370-nm wavelength and an intensity variable (I) from 1 to
20 mW/cm2. The distance between this device and the corneal
surface was set at 5 cm. The UV detector used was a LaserMate
Q-2000 (LaserMate Group, Wessling, Germany) set orthogo-
nally to the radiation wavefront. The detector was previously
calibrated and had an SD of 60.01 mW/cm2. The UV-A
intensity (I) values were measured placing the microscope glass
directly in contact with this device. Beam intensity of the UV-A
emerging from the posterior surface of every microscope slide
(I) when exposed to UV-A (3.0 mW/cm2) was previously
measured. Only slides presenting clear and unscratched glass,
with I values of 2.5276 0.01 mW/cm2, were used in this study.
The speciﬁc absorbance value e of the riboﬂavin solution was
then measured using a spectrophotometer (PerkinElmer
Lambda 25 UV/Vis; PerkinElmer, Waltham, MA). The test
was repeated with 10 different samples. I values emerging from
the posterior surface of each corneal sample were initially
measured as described above. These values at time 0 (t0) were
used as a comparative control for the following readings. Each
cornea, with an approximately 2-mm ring of sclera, was then
mounted on a modiﬁed Franz-type diffusion cell (0.9 mm, 5 mL
receptor volume; SES GmbH–Analysesysteme, Bechenheim,
Germany), with the endothelium facing the receptor compart-
ment. This compartment was constituted by isotonic phosphate
buffer at pH 7.4 and was maintained at 37 6 1°C. Before each
experiment, corneas were equilibrated using 0.5 mL of balanced
salt solution for 10 minutes. Then, 1.0 mL of riboﬂavin solution
was applied. After 30 minutes, the diffusion cells were dis-
mantled, excess donor solution was washed away with balanced
salt solution, and the samples were set on the microscope slide
to be exposed to UV-A radiation. The samples were then
irradiated for 30 minutes at 3 mW/cm2. The intensity of UV-A
light emerging from the posterior surface of each cornea (i0)
was measured every 5 minutes, for a total of 30 minutes.
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Statistical Analysis
Mathematical and statistical analyses were conducted
using Mathematica 7.0 (Wolfram Research Software Inc,
Champaign, IL), and GraphPad Prism (GraphPad Software
Inc, San Diego, CA). The signiﬁcance of differences between
groups was determined by 1-way analyses of variance
followed by Bonferroni post hoc tests for multiple compar-
isons. Differences with P , 0.05 were considered statistically
signiﬁcant in this study.
RESULTS
The I values measured for human corneas are reported
as Supplemental Digital Content 1 (see Table, measured UV-
A output intensities through 12 cornea samples, http://links.
lww.com/ICO/A494); they are expressed in milliwatts per
square centimeter and were measured before and after topical
riboﬂavin application, and every 5 minutes up to 30 minutes
during UV-A exposure. The thickness values (d) of every
sample, expressed in centimeters, are reported in Supplemen-
tal Digital Content 2 (see Table, corneal central thickness and
UV-A absorbance values A and b, http://links.lww.com/ICO/
A495). In these tables are also reported the corneal absor-
bance values (calculated with the Lambert–Beer law) A
(dimensionless) and b (speciﬁc, cm21). These values were
measured before the topical riboﬂavin application (At0, bt0),
after 30 minutes of continuous riboﬂavin soaking (At30, bt30),
and after 5 minutes of UV-A irradiation (ACXL, bCXL). The
corneas showed a signiﬁcant decrease in I values after
30 minutes of riboﬂavin soaking (0.27 6 0.03 mW/cm2)
compared with those at t0 (1.13 6 0.08 mW/cm2, P , 0.01,
2-tail, heteroscedastic); the decrease was signiﬁcant also after
the ﬁrst 5 minutes of UV-A exposure (0.85 6 0.04 mW/cm2).
At 10 minutes of UV-A exposure, I values increased and no
statistical differences were evidenced with t0, before riboﬂa-
vin soaking. Signiﬁcant differences were also present in the
same group for the absorbance values (At30 = 2.43 6 0.124
and bt30 = 52.913 6 2.576 cm21) with respect t0 (t0) (At0 =
0.981 6 0.070 and bt0 = 19.248 6 1.531 cm21; P , 0.01).
DISCUSSION
The EPI-ON model used for this experimentation allows
riboﬂavin corneal penetration similar to the classical protocols,
in which the epithelium is removed (EPI-OFF) before soaking
with the riboﬂavin solution.7 Spectroscopic analysis of UV-A
rays emerging from the endothelial side of the cornea shows
that the intensity is time-varying, not constant as needed for the
application of the Lambert–Beer law.
After 30 minutes of riboﬂavin soaking, the intensity of
radiation emerging from the rear corneal surface (I) is only 0.27
6 0.033 mW/cm2, considered a safe level for the endothelium.
But, soon, that I value increases to 0.85 mW/cm2, which is
beyond the endothelial safety threshold. This increase is due to
intrastromal oxidation (photolysis or “bleaching”) of the
riboﬂavin and its disappearance as a UV-A absorber.
Other authors including Wollensak et al14 have
described the increased endothelial irradiation by a factor of
2 or 3 that occurs during treatment and have prescribed
a superﬁcial riboﬂavin ﬁlm during the cross-linking pro-
cedure. But the use of the precorneal ﬁlm limits cross-linking
to the superﬁcial stroma, thus producing the so-called
“demarcation line” described by Spörl et al.17
By avoiding the use of the precorneal riboﬂavin ﬁlm,
endothelial safety can be achieved instead by lowering UV-A
intensities and shortening the treatment time, and, at the same
time, producing a suitable cross-linking effect. Without the
extremely variable riboﬂavin ﬁlm causing a great variation in
energy absorbed into the cornea, and using UV-A treatment
with lower energy, it should be possible to customize and
optimize treatment for corneas of different thicknesses.
Mathematical Model
The experimental data were used to calculate the main
parameters describing the rate of photolysis of riboﬂavin by
unit of volume (rate equation). The legend of the mathemat-
ical model is described in Table 1. In the cornea soaked with
riboﬂavin, UV-A radiation, I, is absorbed by both corneal
tissues and riboﬂavin molecules. The absorbance of riboﬂavin
in the corneal tissue at time 0 (At0) can be described using the
following formula, according to the Lambert–Beer law:
At0 ¼ 2 ln II0 ¼
eWR
S
þ bd (1)
where e is the speciﬁc absorbance value of the riboﬂavin
solution, already measured; d is corneal thickness; S is the
corneal surface exposed to riboﬂavin soaking (0.64 cm2);
bd is the corneal absorbance, as previously measured; eWR/S
is the absorbance of the corneal tissue due to riboﬂavin; and
WR, is the amount of riboﬂavin in corneal stroma, calculated
from the ratio I/I0.
At t0, the absorbance, due to riboﬂavin (WR) accumu-
lated in stroma, can be calculated as follows:
At30
d2 0:005
2
At0
d
¼ e WR
S · ðd2 0:005Þ (2)
TABLE 1. Legend of the Mathematical Model
RA(z,t) = concentration (mg/cm3) of riboﬂavin available for cross-linking at
depth z in the corneal thickness at time t
I(z,t) = intensity of the UV-A radiation in the corneal thickness at depth z and
time t
vIR(z,t) = intensity of the UV-A radiation absorbed by the available riboﬂavin
contained in an inﬁnitesimally thick corneal layer dz at depth z and at time t
S = exposed surface area
Wmol = molecular weight
e = speciﬁc riboﬂavin absorbance
a = speciﬁc exhaust solution absorbance
bt0 = speciﬁc corneal UV-A absorbance (cm21) before topical application of
the riboﬂavin solution
P = photolysis probability for a riboﬂavin molecule during the cross-linking
process
g = proportionality factor [approximately 935,500 (m2$s22) for riboﬂavin and
639,727 (m2$s22) for riboﬂavin phosphate]
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Having measured the corneal thickness d in centimeters,
a correction factor (0.005) has been used for human corneal
thickness, considering epithelium removal (50 mm of sup-
posed thickness as reported in the literature).18
The key issue in this model is that CXL consumes the
riboﬂavin molecules within the cornea, thus, contribution to
UV-A absorption from riboﬂavin decreases during the pro-
cedure. Therefore, the Lambert–Beer law is not sufﬁcient in
and of itself to describe the phenomenon.
For the sake of ease, in the ensuing mathematical
description, the cornea will be assumed to be substantially
planar. With this simpliﬁcation, the intensity I of UV-A in the
cornea may be considered a function only of the time t and
distance (depth) z from the epithelial surface.
Hence, the intensity of UV-A in a cornea soaked with
riboﬂavin can be described by the following differential
Equation 3:
vIðz; tÞ
vz
¼ 2 Iðz; tÞ · ½ðe2aÞ ·RAðz; tÞ þ a ·RAðz; 0Þ þ b
(3)
where a is the speciﬁc absorbance value of the exhaust
riboﬂavin solution; t is the time elapsed from the beginning of
UV-A irradiation (at the instant t = 0); z is the distance between
a considered point in the stroma and the epithelial surface; I(z,t)
is the intensity of the UV-A radiation in the corneal thickness
at depth z and time t; vIR(z,t) is the intensity of UV-A radiation
absorbed by the available riboﬂavin contained in an inﬁnites-
imally thick corneal layer dz at depth z and at time t; RA(z,t) is
the concentration (milligram per cubic centimeter) of riboﬂavin
available for cross-linking at depth z in the corneal thickness at
time t; and a · [RA(z,0) 2 RA(z,t)] is the contribution of the
products of photolysis of riboﬂavin (herein referred also as
“exhaust solution”) to the UV-A absorbance.
The time rate of riboﬂavin consumption during CXL is
not described by the Lambert–Beer law. The following rate
Equation 4 is adapted to describe the photolysis of riboﬂavin:
vRAðz; tÞ
vt
¼ 2 e ·P
g
· Iðz; tÞ ·RAðz; tÞ (4)
where P is the photolysis probability for a riboﬂavin molecule
during the cross-linking process and eg is
a proportionality factor.
The probability of riboﬂavin photolysis is considered
constant in this model at any point within the cornea and at
any time during cross-linking treatment.
g is calculated as follows: U being the number of UV-A
photons absorbed by riboﬂavin in an inﬁnitesimally thick
layer of the cornea in time dt, the corresponding energy 2S ·
vIR(z,t) · dt absorbed by this layer is as follows:
2 S · vIRðz; tÞ · dt ¼ U · h · c
l
(5)
where c is the speed of light in a vacuum, S is the exposed
corneal area, h is the Planck constant, and l is the UV-
A wavelength.
The number of molecules of riboﬂavin M split by
photolysis in an inﬁnitesimally thick layer of the cornea by
UV-A in time dt is assumed proportional to the number of
photons absorbed by riboﬂavin:
M ¼ P ·U (6)
where P is the probability that a photon succeeds in splitting
a riboﬂavin molecule. The corresponding riboﬂavin con-
sumption in the inﬁnitesimally thick layer dz of the cornea
during time dt is as follows:
S · vRAðz; tÞ · dz ¼ 2M ·WmolN (7)
where Wmol is the molecular weight of riboﬂavin and N is the
Avogadro number. By combining the above equations,
vIRðz; tÞ · dt ¼ h · cPl ·
N
Wmol
· vRAðz; tÞ · dz (8)
According to the Lambert–Beer law, the amount of radia-
tion vIR(z,t) absorbed into the inﬁnitesimally thick layer by
the available riboﬂavin is proportional to the incident radia-
tion I(z,t) and to the product of the concentration of available
riboﬂavin RA(z,t) by thickness dz of the crossed layer,
whereby,
vIRðz; tÞ ¼ 2 e · Iðz; tÞ ·RAðz; tÞ · dz (9)
Being:
g ¼ h$c
l
·
N
Wmol
(10)
So, rate Equation 4 is obtained.
The parameter g is inversely proportional to the UV
wavelength and also to the molecular weight of the target
substance (riboﬂavin), according to the proportionality
constant:
hcN ¼ 0:11314208  J$m$mole2 1 (11)
For a wavelength of 370 nm,
h$c$N
l
¼ 305789:41  J$mole2 1 (12)
This value represents the energy per mole of UV-A
photons (sometimes referred to as “1 Einstein”).
The parameter g is equal to 935,500 (m2$s22) for
riboﬂavin and 639,727 (m2$s22) for riboﬂavin-5-phosphate.
It represents the ratio between the energy of 1 mole of 370-nm
UV-A photons and the mass of a mole of riboﬂavin. Then,
P
g indicates the number of consumed riboﬂavin moles for 1 J
of UV-A photons absorbed by this substance. Using Math-
ematica 7.0 software, the following value was calculated from
Equations 3 and 4 and from the experimental values reported
in Supplemental Digital Content 1 (see Table 1, http://links.
lww.com/ICO/A494):
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Pg
¼ 0:14  mg$J2 1 ¼ 1:4$102 7m2 2$s2 (13)
where P is the probability of splitting a riboﬂavin-5-
phosphate molecule with a UV-A photon (wavelength 370
nm) and is calculated from Equation 13 to approximately 9%.
Theoretical Results of the Model
A “customized CXL plot” can be obtained from
differential Equations 3 and 10 previously described. In this
diagram (Fig. 1), corneal thicknesses (x axis, expressed in
centimeters) are plotted against the UV-A source intensity
(y axis, expressed in Joule per square centimeter) at different
treatment times (expressed in minutes). The diagram has been
built using average speciﬁc absorbance and riboﬂavin corneal
concentrations after soaking (see Supplemental Digital Con-
tent 1 and 2, http://links.lww.com/ICO/A494, http://links.
lww.com/ICO/A495) and assuming the hypothesis that
products of photolysis of riboﬂavin do not contribute to
shield against UV-A (a = 0). Once corneal thickness and UV-
A source intensity have been assessed, the treatment time can
be derived. The longer the treatment time is, the deeper is the
effect produced, but from the safety point of view, the limit of
0.35 mW/cm2 is never exceeded and the longest treatment
time used is 15 minutes. Moreover, the 0 plot represents the
safety limit conditions for treatment, showing that an UV-A
intensity of 1.8 mW/cm2 should not be used on the human
cornea with a thickness of less than 0.054 cm, thus presenting
a slightly more conservative prescription for UV-A ﬂuence
than may be necessary.
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FIGURE 1. Maximum UV fluence in mW/cm2 (y axis) versus
corneal minimal thickness in centimeters (x axis) to assure less
than 0.3 mW/cm2 on the corneal endothelium. The number
attached to each line on the chart is the number of minutes for
application of UV light needed to accomplish effective cross-
linking. The 0 plot represents the safety limit conditions for
treatment, showing that an UV-A intensity of 1.8 mW/cm2
should not be used on the human cornea with a thickness less
than 0.054 cm.
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